Contribution of MUTYH Variants to Male Breast Cancer Risk: Results From a Multicenter Study in Italy
Piera Rizzolo(Sapienza University of Rome), Laura Ottini(Mount Sinai Hospital), Ines Zanna(Piedmont Reference Center for Epidemiology and Cancer Prevention), Simonetta Bianchi(University of Florence), Jacopo Azzollini(Fondazione IRCCS Istituto Nazionale dei Tumori), Siranoush Manoukian(Fondazione IRCCS Istituto Nazionale dei Tumori), Marco Montagna(Azienda Ospedale - Università Padova), Anna Coppa(Sapienza University of Rome), Liliana Varesco(Istituti di Ricovero e Cura a Carattere Scientifico), Agostino Bucalo(Sapienza University of Rome), Giovanna Masala(Piedmont Reference Center for Epidemiology and Cancer Prevention), Laura Cortesi(Azienda Ospedaliero-Universitaria di Modena), Domenico Palli(Piedmont Reference Center for Epidemiology and Cancer Prevention), Valentina Silvestri(Cancer Research UK Cambridge Center), Virginia Valentini(Sapienza University of Rome), Irene Catucci(IFOM), Bernardo Bonanni(European Institute of Oncology), Daniele Calistri(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Antonio Russo(University of Palermo), Alessandro Spinelli(IRCCS Materno Infantile Burlo Garofolo), Paolo Peterlongo(IFOM), Paolo Radice(IFOM), Maria Grazia Tibiletti(University of Insubria), Stefania Tommasi(Istituto Tumori Bari), Alessandra Viel(Centro di Riferimento Oncologico), Veronica Zelli(University of L'Aquila)
Cited by 34
Related Papers
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
|The American Journal of Human Genetics|2018|1.2k
Meat, Fish, and Colorectal Cancer Risk: The European Prospective Investigation into Cancer and Nutrition
|JNCI Journal of the National Cancer Institute|2005|865
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|724
Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis
|Nature Communications|2020|694